Exam 8: Anticoag/Psych Flashcards
anticoagulant
works against the formation of a clot - disrupt coag cascade
most effective on venous thrombosis (damage occurs at distant site like PE)
contra: risk of bleeding (uncontrolled hemorrhage, recent surgery, lumbar puncture, etc.)
antiplatelets
inhibit the platelet clumping/aggregation (clotting)
most effective on arterial thrombosis (localized damage)
thrombolytic
destroys existing clot - promote lysis of fibrin
tPA - speeds up the conversion of plasminogen to plasmin that degrades the fibrin mesh and breaks up a clot
indications for all
DVT, CVA, PE, procedures
ADRs for all
bleeding/hemorrhage, spinal/edidural hematoma, hemorrhagic stroke
always #1 concerned for hemorrhage (intracranial bleed)
AMS and projectile vomitting -> increased ICP
contras for all
uncontrolled bleeding, recent procedure/puncture
heparin
anticoagulant - high risk med
enhance antithrombin - prevent clots, doesn’t break down
rapid acting, SQ/IV
contra: thrombocytopenia
preferred during pregnancy
ADR: HIT, hypersensitivity, local irritation/ecchymosis
labs: antifactor Xa (0.3-0.7), aPTT (60-80 secs), platelet counts - every 6 hrs until stable and then less often and will titrate
HIT
immune - decreased platelet counts (occurs 2-5% of pts) -> monitor platelets closely (30% loss or more)
and worry about bleeding -> blue/purple fingers/toes
antibody formation -> lab = HIT immunoassay to detect
promotes thrombosis and loss of circulating platelets
immediately dc and notify provider
aPTT normal
40 secs
enoxaparin/dalteparin
anticoagulant - LMWH
MOA: inactivates factor Xa and thrombin
SQ/IV
comes in fixed (weight-based) dosing/does not require lab monitoring (at home)
same ADRs
more expensive than heparin
warfarin
anticoagulant - Vit K antagonist
PO - delayed onset (not for emerg), prevents activation of vit K (needed for VII, IX, X, and prothrombin)
preventative for Afib, DVT, MI/TIA
ADR: teratogenic, similar to heparin
many interactions - heparins, antiplatelets (bleeding), seizure meds, oral contraceptives, rifampin (decrease), antifungals, cimetidine, amiodarone (increase)
vitamin K foods -> don’t need to avoid, just need to make sure no spikes in vitamin K (steady)
labs: PT/INR (goal 2-3)
dabigatran
anticoagulant - direct thrombin inhibitor
PO -> empty stomach, compares to warfarin (less risk of bleeding, labs less often, faster onset, fixed dose, fewer interactions)
ADR: lower risk of bleeding than warfarin, GI
don’t need to check labs as often, stop 1-3 days prior to surgery
argatroban
anticoagulant - direct thrombin inhibitor
IV, used in place of heparin when HIT occurs
hypersensitivity w/thrombolytics or contrast media
rivaroxaban
anticoagulant - factor Xa inhibitor -> “xa” in the word (Xarelto)
PO, DVT/PE prophylaxis, check renal function, teratogenic, cannot use with hepatic issues
apixaban
anticoagulant - factor Xa inhibitor -> “xa” in the word
(Eliquis)
ASA
antiplatelet - aspirin
MOA: irreversibly inhibits COX enzyme 1 -> blocks synthesis of TXA2 so no platelet activation and no vasoconstrict
uses: stroke/TIA, angina, MI, bypass/stent
ADR: risk for GI bleed
**doubles bleeding for 7-10 days (lifetime of platelet), stop 1 wk before surg
clopidogrel/ticagrelor
antiplatelet - alone or w/ASA (for ACS)
MOA: ADP receptor antagonist - stops ADP stimulated platelet aggregation
uses: stents, CVA, ACS, PAD
ADR: TTP, GI, less bleeding than ASA
tirofiban
antiplatelet - GP IIa/IIIb antagonist **highlighted this drug in class
IV, most effective - “super ASA”, used w/ASA and heparin
use w/ACS during cath lab -> prevent reocclusion
reversible block of receptors, effects last 24 - 48 hours
alteplase/reteplase/tenecteplase
thrombolytics
dissolve existing thrombi -> convert plasminogen back to plasmin
acute use for MI/CVA/PE (low dose for central line)
alteplase = tPA
give blood products when ADR of bleeding
protamine sulfate
antidote to heparin, neutralizes
phytonadione
vitamin K antidote to warfarin, PO or IV= dilute first and infuse slow (anaphylaxis risk)